What Does A Global Supply Chain Look Like for CGT? Defining End-To-End Logistics

18 Jan 2023
Supply Chain & Technical Operations Track
QuickSTAT Global Life Science Logistics
World Courier

11:00am Chair Introduction

Senior Representative, Exacis


11:05am Presentation: TBA

Maia Hansen, Chief Operating Officer, Athersys


11:20am Presentation: Planning Cell & Gene Supply Chain Logistics

  • Clinical through commercial
  • Speed to Scale – Leveraging Experience, New Ideas and Technology

Kent Thorup, Regional Vice President, QuickSTAT


11:35am Presentation: Overcoming challenges in Cell & Gene Therapy manufacturing by leveraging Strategic Sourcing

Benoit Bossuge, Head of Strategic Sourcing, CRISPR Therapeutics


11:50am Presentation: Practical Advice and Logistics Considerations to Bring Cell and Gene Therapies to Patients

Overview of logistics requirements of cell and gene therapies and practical advice on how to bring cell and gene therapies to patients.

  • Solutions and limitations for the distribution of time critical therapies
  • Technical equipment and processes for frozen up to cryogenic storage and distribution and how to assure chain of custody
  • Examples of challenges of the current regulations and logistics consequences for genetically modified therapies

Jennifer Fenwick, Senior Manager, Personalized Supply Chain, WorldCourier


12:05pm Closing Panel with Q&A

With all session participants


Benoit Bossuge
Head of Strategic Sourcing
CRISPR Therapeutics
Jennifer Fenwick
Senior Manager, Personalized Supply Chain
World Courier
Kent Thorup
Regional Vice President
QuickSTAT Global Life Science Logistics
Maia Hansen
Chief Operating Officer